Tanya Pollitt, Denver Science News Examiner

A new test, developed at the University of Colorado Cancer Center, helps reduces the risk of death by 36 percent in advanced lung cancer by identifying a biomarker known as the EGFR protein.

In a press release, Professor Fred R. Hirsch of the University of Colorado School of Medicine, co-developer of the test, said, “We are moving from a one-size-fits-all model to more personalized medicine in lung cancer. This is a completely new paradigm in treating cancer.”